Drug Topics
JUNE 28, 2023
Employing AI-driven technology ensures accurate and timely compliance with industry regulations, mitigates audits and fines, and helps forecast accurate reimbursements.
Pharmacy Times
JUNE 28, 2023
Investigators identified potential ways to inhibit the HpdBCA decarboxylase, which can reduce the production of p-cresol and make CDI more susceptible to bacteria in the gut microbiome.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JUNE 28, 2023
Researchers of a new paper discuss the inconsistencies between gene and cell therapy indications and payor coverage.
Pharmacy Times
JUNE 28, 2023
The growing volume of drugs sold through illegal online pharmacies are estimated to generate 10 times higher adverse event rates than drugs sold through legal pharmacies.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
JUNE 28, 2023
Newly proposed changes to the Federal Trade Commission’s pre-merger notification requirements would give regulators more information to review during a deal’s initial waiting period—likely giving t | The federal regulator said its proposed updates would enable more efficient review of pending deals during the initial 30-day waiting period. As is, the changes are estimated to add, on average, more than 100 hours to companies' paperwork burden per filing.
STAT
JUNE 28, 2023
The Gates Foundation unveiled plans Wednesday to fund a long-awaited trial for what, if proven effective, would be the first new tuberculosis vaccine in over a century. The 26,000-person, Phase 3 study, set to begin next year, will test a vaccine known as M72/AS01 that showed promising results from a smaller trial in 2019. The findings stoked excitement at the time.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
JUNE 28, 2023
A bipartisan group of 61 U.S. senators and 233 members of the U.S. House of Representatives signed onto a joint letter asking the Centers for Medicare & Medicaid Services to approve reforms.
Pharmacy Times
JUNE 28, 2023
Evidence shows vitamin D deficiency is linked to abnormal dopamine signaling disorders in neurodevelopment, including schizophrenia.
Fierce Healthcare
JUNE 28, 2023
Companies continue to ramp up investments in resources to support employees' mental health and wellbeing as workers grapple with work-related stress, burnout, depression and anxiety. | Digital mental health company Headspace is building on its partnership with Virgin Pulse to make it easier for employers and health plans to provide a range of mental health resources to their employees and plan members.
Pharmacy Times
JUNE 28, 2023
As the battle over abortion rages, mifepristone has become the new center of the legal fight between anti-abortion advocates and the FDA.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
JUNE 28, 2023
Menopause is having its moment. High-profile investments and startups with celebrity names attached have brought long-overdue attention to this once-taboo area of women's health. | Menopause is having its moment. High-profile investments and startups with celebrity names attached have brought long-overdue attention to this once-taboo area of women's health.
Pharmacy Times
JUNE 28, 2023
During the pandemic, many community pharmacists also gained the authority to provide routine vaccinations for child populations.
Fierce Healthcare
JUNE 28, 2023
UnitedHealthcare will nix out-of-pocket costs for its 24/7 Virtual Visits in some of its fully insured plans beginning July 1. | UnitedHealthcare will nix out-of-pocket costs for its 24/7 Virtual Visits in some of its fully insured plans beginning July 1.
STAT
JUNE 28, 2023
Thanks to advances in treatments, children’s chances of surviving cancer are higher than ever before. But the trauma that patients experience as they deal with the disease can pose a lifelong risk to their mental health, according to a recent analysis published in JAMA Pediatrics. The meta-analysis of 52 clinical studies measured the prevalence and severity of psychological disorders in over 20,000 young cancer survivors.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
JUNE 28, 2023
Calm Health, the mental health offering of meditation app Calm, is tapping the Mayo Clinic to help design digital mental health programs to help cancer patients manage anxiety, depression and menta | The upcoming digital mental health program will be available to Calm Health customers and “will be designed for all adults with cancer,” according to the announcement.
Fierce Pharma
JUNE 28, 2023
Eco-minded AstraZeneca speaks for the trees. | AstraZeneca—often on the frontlines of environmental stewardship—is expanding its AZ Forest program to the tune of $400 million. With that new investment, the company is raising its commitment to plant and nurture 200 million trees across six continents by 2030—the same year AstraZeneca aims to halve its environmental footprint across its entire value chain.
Fierce Healthcare
JUNE 28, 2023
Mark Cuban Cost Plus Drug Company has announced its latest move, with the firm stepping into the male fertility space in partnership with Posterity Health. | Mark Cuban Cost Plus Drug Company has announced its latest move, with the firm stepping into the male fertility space in partnership with Posterity Health.
STAT
JUNE 28, 2023
Until the early 20th century, America regularly experienced brutally destructive urban fires. Conflagrations like the 1871 Great Chicago Fire, which destroyed more than 17,000 buildings and left 100,000 people homeless, were thought to be unfortunate but inevitable: Large numbers of buildings in close proximity naturally led to large fires. But then, conscious changes to the built environment eliminated large urban fires.
Fierce Healthcare
JUNE 28, 2023
The Joint Commission is kicking off a new advanced, voluntary certification for hospitals with processes in place to address healthcare disparities and promote equity among staff, the accreditation | Effective July 1, hospitals and critical access hospitals will be able to apply for an optional certification distinguishing those that make equity a strategic priority, the accreditation organization said.
Fierce Pharma
JUNE 28, 2023
With a spring approval in hand, Reata Pharmaceuticals has been waiting patiently to launch its first commercial product, Skyclarys. | After an FDA thumbs up on Reata's approval supplement for Skyclarys, analysts feel confident the newly commercial-stage company can meet—or potentially even exceed—a $45.9 million sales target for 2023.
Fierce Healthcare
JUNE 28, 2023
Author Health banked $115 million for its new platform offering care and treatment for Medicare Advantage members with serious mental illness and substance use disorders. | Author Health banks $115 million for its new platform offering care and treatment for Medicare Advantage members with serious mental illness and substance use disorders. Humana will be the first to launch the startup’s services in conjunction with CenterWell Senior Primary Care in South Florida.
Pharmacy Times
JUNE 28, 2023
The microRNA member miR-204-5p inhibits apoptosis in melanoma cells treated with dacarbazine or when overexpressed.
STAT
JUNE 28, 2023
A young girl, maybe 5 or 6 years old, had come into Yoram Unguru’s clinic with acute lymphoblastic leukemia, the most common of all childhood cancers. One of the drugs needed for treatment was methotrexate. The only problem was that the drug was in short supply. “Oftentimes we can cure kids of their disease, but we can’t do that without the drugs,” said Unguru, a pediatric hematologist oncologist at Children’s Hospital at Sinai in Baltimore and the Johns Hopkin
Fierce Pharma
JUNE 28, 2023
Eton Pharmaceuticals’ dehydrated alcohol injection didn’t pass muster with the FDA, instead receiving a complete response letter (CRL) raising flags the company believes are “addressable.” | The dehydrated alcohol injection was turned down due to problems with its chemistry manufacturing and controls, issues which the company believes are addressable, it said in a statement.
STAT
JUNE 28, 2023
Drug shortages are a growing problem in the U.S., and a shortage of livesaving cancer drugs in particular has reached crisis levels. On the latest episode of the “First Opinion Podcast,” oncologist Kristen Rice explains that drug shortages have been happening for several years but have been progressively worsening in the past few months.
Fierce Pharma
JUNE 28, 2023
Merely a month into an FDA approval, AbbVie and Genmab’s bispecific drug Epkinly has chalked up a positive readout that might enable an expansion in blood cancer, although the exact regulatory path | Merely a month into an FDA approval, AbbVie and Genmab’s bispecific drug Epkinly has chalked up a positive readout that might enable an expansion in blood cancer, although the exact regulatory path remains unclear.
STAT
JUNE 28, 2023
For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible. The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts.
The Checkup by Singlecare
JUNE 28, 2023
Man’s best friend is really the perfect name for our sweet little pooches. We love them so much and would basically do anything to make sure our dogs are happy and healthy. So when our dogs get sick and can’t tell us what’s wrong, we rush them to the vet and go with whatever they prescribe. If your vet has recently prescribed your canine metronidazole and you’d like to learn more about it, we’ve gone to the veterinary medicine experts to find out everything you need to know.
STAT
JUNE 28, 2023
In 20 states, people are once again breathing in hazardous smoke from Canadian wildfires. The return of the air quality warnings, just weeks after the first took much of the U.S. by surprise, are a reminder that we will keep experiencing these conditions in the absence of integrated and health-driven climate adaptation policies. As global temperatures continue to rise, we are likely to see more periods of extreme and prolonged heat as well as reduced rainfall and humidity, which in turn increase
Fierce Pharma
JUNE 28, 2023
Pfizer is on an FDA heater. | Pfizer is on an FDA heater. With a blessing Wednesday for once-weekly growth hormone deficiency (GHD) drug Ngenla, the New York pharma giant has racked up four approvals from the agency over the last five weeks.
STAT
JUNE 28, 2023
WASHINGTON — Most of the medical community has acknowledged that racism is baked into many of its clinical tools: pulse oximeters and kidney function calculators are prime examples. But as presentations at a conference Tuesday showed, physicians remain divided on when to remove race from calculators and algorithms — and crucially, what characteristics should replace it.
Drug Store News
JUNE 28, 2023
Peggy Noonan, renowned columnist, author, political analyst and former presidential speechwriter will lead a timely conversation on culture, politics and current events.
STAT
JUNE 28, 2023
Good morning, everyone, and how are you today? We are doing just fine, thank you. Given that this is already the middle of the week and we have survived this far, no reason not to continue, yes? Just consider the alternatives. In fact, this modest accomplishment calls for celebration. So please join us in quaffing a ritual cup of needed stimulation.
Pharmaceutical Commerce
JUNE 28, 2023
In an interview with Pharma Commerce Editor, Nicholas Saraceno, Courtney Granville, Director, Scientific Affairs, Drug Information Association, discusses issues impacting broader supply chains.
Expert insights. Personalized for you.
187 
Let's personalize your content